IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K306. A total of 78 filers reported holding IDERA PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 1.04 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $15,000 | -44.4% | 11,920 | -17.8% | 0.00% | – |
| Q1 2018 | $27,000 | -3.6% | 14,502 | +9.6% | 0.00% | – |
| Q4 2017 | $28,000 | -42.9% | 13,237 | -39.1% | 0.00% | – |
| Q3 2017 | $49,000 | +133.3% | 21,719 | +71.5% | 0.00% | – |
| Q2 2017 | $21,000 | -60.4% | 12,662 | -41.1% | 0.00% | – |
| Q1 2017 | $53,000 | +60.6% | 21,488 | -1.1% | 0.00% | – |
| Q4 2016 | $33,000 | -8.3% | 21,728 | +55.8% | 0.00% | – |
| Q3 2016 | $36,000 | +125.0% | 13,950 | +33.5% | 0.00% | – |
| Q2 2016 | $16,000 | -20.0% | 10,450 | +4.5% | 0.00% | – |
| Q1 2016 | $20,000 | -33.3% | 10,000 | +2.2% | 0.00% | – |
| Q4 2015 | $30,000 | -25.0% | 9,783 | -18.6% | 0.00% | – |
| Q3 2015 | $40,000 | +53.8% | 12,021 | +69.3% | 0.00% | – |
| Q2 2015 | $26,000 | +1200.0% | 7,100 | +1320.0% | 0.00% | – |
| Q1 2015 | $2,000 | -50.0% | 500 | -50.0% | 0.00% | – |
| Q4 2014 | $4,000 | +100.0% | 1,000 | 0.0% | 0.00% | – |
| Q3 2014 | $2,000 | -33.3% | 1,000 | 0.0% | 0.00% | – |
| Q2 2014 | $3,000 | -25.0% | 1,000 | -0.7% | 0.00% | – |
| Q1 2014 | $4,000 | – | 1,007 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 2,030,604 | $4,285,000 | 0.70% |
| Virtus ETF Advisers LLC | 180,348 | $381,000 | 0.48% |
| Bain Capital Public Equity Management, LLC | 4,564,744 | $9,632,000 | 0.35% |
| Baker Brothers Advisors | 18,315,802 | $38,646,000 | 0.34% |
| Stanley-Laman Group, Ltd. | 483,773 | $1,021,000 | 0.22% |
| FIRST MIDWEST BANK TRUST DIVISION | 493,689 | $1,042,000 | 0.13% |
| GMT CAPITAL CORP | 3,875,546 | $8,178,000 | 0.08% |
| Vident Investment Advisory, LLC | 640,270 | $1,351,000 | 0.06% |
| SABBY MANAGEMENT, LLC | 307,987 | $650,000 | 0.06% |
| Palo Alto Investors LP | 616,355 | $1,301,000 | 0.06% |